COVID-19 vaccine developer Moderna (Nasdaq:MRNA) has named Arpa Garay as its chief commercial officer starting May 31, 2022.
Garay worked more than 15 years at Merck & Co. (NYSE:MRK). In February, she was promoted to the post of chief marketing officer for Merck’s human health division. Garay also was a member of the company’s executive committee.
Arpa Garay
At Moderna, Garay will report directly to CEO Stéphane Bancel.
Garay has won several awards. She was named a G100 Next Gen Leader, Fortune named her as one of the “Most powerful Women: Next Gen” while Business Insider India and the Philadelphia Business Journal included her in rankings of leaders under 40.
“I am grateful and excited to work with an inspiring team and build a commercial organization to bring the transformative impact of Moderna’s mRNA science to improve lives around the world across many diseases,” Garay said in a press release.
Merck has seen a number of its executives hit the exits in the past year, including former CEO Ken Frazier.